A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined Inclusion/Exclusion Criteria apply.
Santa Monica, California 90404, United States
Tampa, Florida 33609, United States
Liège, 04000, Belgium
Woluwe-Saint-Lambert, 01200, Belgium
Inashiki-gun, Japan
Kamimashiki-gun, 861-3101, Japan
Kawasaki-shi, 211-8533, Japan
Shinjuku-ku, 160-0023, Japan
Lublin, 20-573, Poland
Poznan, 61-731, Poland
Santiago de Compostela, 15706, Spain
Valencia, 46026, Spain
Liverpool, L14 3LB, United Kingdom